Title for MeetingAbstracts
Alphabetical listing of titles
Efficacy and Safety of Polymyxin B in the Treatment of Infections Caused by Multi-Drug Resistant Gram-Negative Organisms.
Efficacy and Safety of Protease Inhibitor (PI) Switching to Nevirapine (NVP) in HIV Patients with Undetectable Viral Load: Results after 3 Years.
Efficacy and safety of quadruple combination therapy in treatment experienced HIV/AIDS patient.
Efficacy and safety of Ritonavir+Saquinavir+d4T+ddI versus nelfinavir+Efavirenz+d4T+ddI in HIV-infected children with prior antiretroviral exposure.
EFFICACY AND SAFETY OF RITONAVIR/ INDINAVIR 100/400 MG BID IN COMBINATION WITH TWO NUCLEOSIDE ANALOGUES IN ANTIRETROVIRAL TREATMENT NAIVE HIV-INFECTED INDIVIDUALS.
Efficacy and safety of rosiglitazone and pioglitazone compared to traditional antidiabetic agents for the treatment of type 2 diabetes mellitus: a systematic review.
Efficacy and Safety of Sequential (IV to PO) Moxifloxacin (MXF) for Treatment of Community-Acquired Pneumonia (CAP) Due to Atypical Pathogens.
Efficacy and safety of Stealth liposomal doxorubicin (DOX-SL) in AIDS-related Kaposi's sarcoma. The International Dox-SL Study Group.
Efficacy and safety of substiva (efavirenz) in the french TAU (Temporary Authorization for Use) : A programme providing rapid access to drugs prior to registration.
Efficacy and safety of switch to 3TC 300 mg QD vs. continued 3TC 150 mg BID in subjects with virologic suppression on stable 3TC/d4T/PI therapy (COLA4005): final 24-week results.
Efficacy and Safety of Switch to GW433908/ritonavir 200mg (908/r) QD in Subjects Initiating Therapy with Amprenavir/ritonavir 200mg (APV/r) QD: ESS40001(CLASS).
Efficacy and safety of switching from protease inhibitors to efavirenz in clinically stable HIV patients.
Efficacy and Safety of Telithromycin (800 mg once daily) for 5 or 7 Days vs Clarithromycin (500 mg twice daily) for 10 Days in the Treatment of Patients with Community-Acquired Pneumonia.
Efficacy and safety of tenofovir DF (TDF) versus stavudine (d4T) when used in combination with lamivudine and efavirenz in antiretroviral naive patients: 96-week preliminary interim results.
Efficacy and safety of tenofovir disoproxil fumarate (TDF) versus stavudine (d4T) when used in combination with lamivudine (3TC) and efavirenz (EFV) in HIV-1 infected patients naive to antiretroviral therapy (ART): 48-week interim results.
Efficacy and safety of the combination of ritonavir plus saquinavir, with two nucleoside analogues.
Efficacy and safety of the combination of tenofovir (TFV) and didanosine (DDI) as a backbone regimen.
Efficacy and safety of the HIV protease inhibitor indinavir sulfate (MK 639) at escalating doses.
Efficacy and safety of therapy with interferon and ribavirin in HIV infected patients with chronic hepatitis C.
Efficacy and safety of trimethoprim-sulfamethoxazole desensitization in HIV-infected patients.
Efficacy and safety of trimethoprim-sulfamethoxazole desensitization in patients infected with human immunodeficiency virus.
Efficacy and safety of triple combination therapy with Invirase (saquinavir/SQV/HIV protease inhibitor), Epivir (3TC/lamivudine) and Retrovir (ZDV/zidovudine) in HIV-infected patients.
Efficacy and safety of twice weekly dapsone as prophylaxis for Pneumocystis carinii pneumonia.
Efficacy and Safety of Voriconazole (VORI) in the Treatment of Invasive Fungal Infection in Children.
Efficacy and safety of Zidovudine and Zalcitabine combined with combination of herbs in the treatment of HIV-infected Thai patients.
Efficacy and safety profile of antiretroviral treatment of ritonavir in combination with zidovudine (ZDV/AZT) and zalcitabine (ddC) for HIV/AIDS patients in San Lazaro Hospital.
EFFICACY AND SAFETY RELATED TO INDINAVIR AND NEVIRAPINE PLASMA CONCENTRATIONS IN A RANDOMISED CONTROLLED TRIAL COMPARING INDINAVIR AND NEVIRAPINE VERSUS INDINAVIR CONTAINING REGIMEN IN HIV-1 INFECTED PATIENTS (TRIANON-ANRS081 STUDY).
Efficacy and Tolerability of a 5-day Course of a New Ketolide Antimicrobial, Telithromycin (HMR 3647), for the Treatment of Acute Exacerbations of Chronic Bronchitis (AECB) in Patients with COPD.
Efficacy and Tolerability of a 5-Day Course of a New Ketolide Antimicrobial, Telithromycin (HMR 3647), for the Treatment of Acute Sinusitus.
Efficacy and tolerability of efavirenz-containing regimen in Brazilian children on virological failure to 2 nucleoside reverse transcriptase inhibitors (NRTI) with or without protease inhibitors (PI).